Trial site
The Second People's Hospital of Hefei
- 21running trials
- 9closed trials
The trials here
What the 30 trials at this site are about, from their registry records.
- Conditions
- Obesity19 trials
- Type 2 diabetes14 trials
- Insomnia2 trials
- Migraine2 trials
- Osteoarthritis2 trials
- Chronic kidney disease1 trial
- Liver and biliary tract cancer1 trial
- Myeloproliferative neoplasms1 trial
- Obstructive sleep apnoea1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 325 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting10 trials
- Completed8 trials
- Active, not recruiting6 trials
- Not yet recruiting5 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company17 trials
- Pfizer4 trials
- Hoffmann-La Roche2 trials
- Anhui Provincial Hospital1 trial
- Boehringer Ingelheim1 trial
- and 5 more
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Not yet recruiting
Recruiting
Not yet recruiting
A Multicenter Observational Study of Daridorexant in the Treatment of Insomnia
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity12 recruiting
- Type 2 diabetes6 recruiting
- Insomnia1 recruiting
- Liver and biliary tract cancer1 recruiting
- Obstructive sleep apnoea1 recruiting
- Osteoarthritis1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Completed
Completed
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Site data: ClinicalTrials.govUpdated 18 Nov 2026